Luminex Corporation Receives FDA Clearance for ARIES C. difficile Assay

Sample to answer test provides detection of both toxin A and B AUSTIN, Texas, July 24, 2017 -- (Healthcare Sales & Marketing Network) -- Luminex Corporation (NASDAQ: LMNX) today announced that it has received FDA clearance for the ARIES® C. diffici... Diagnostics, FDA Luminex, ARIES, C. difficile Assay, C. difficile
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news